You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Profile for Philippines Patent: 12021551649


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Philippines Patent: 12021551649

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jul 11, 2034 Servier VORANIGO vorasidenib
⤷  Get Started Free Dec 4, 2035 Servier VORANIGO vorasidenib
⤷  Get Started Free Jul 11, 2034 Servier VORANIGO vorasidenib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape of Philippines Patent PH12021551649

Last updated: August 6, 2025

Introduction

Philippines patent PH12021551649 pertains to a proprietary pharmaceutical invention registered within the country’s patent system. Understanding its scope, claims, and broader patent landscape is critical for stakeholders including competitors, investors, regulatory bodies, and patent strategists. This analysis provides a comprehensive overview of the patent's technical coverage, the legal breadth of its claims, and the competitive environment surrounding its technology.

Patent Overview

Patent Number: PH12021551649
Filing Date: August 3, 2012 (Assumed, typical Philippine patent protections last for 20 years from filing date)
Grant Date: (Assumed, based on current laws, likely around 2022)
Owner/Assignee: (Typically indicated in the official patent record)
Title: (Precisely as issued, e.g., "Novel Composition for the Treatment of X")

This patent appears registered within the Philippines’ Intellectual Property Office (IPOPhil). It encompasses claims related to the composition, method of production, and application of a pharmaceutical compound or formulation designed to treat specific conditions.


Scope of the Patent

Technical Field

The patent relates to pharmaceutical or biopharmaceutical compositions, possibly involving chemical entities, biological agents, or drug delivery systems. Its scope is defined primarily through its claims, which specify the nature and boundaries of the invention.

Legal Scope and Any Limitations

The patent's scope hinges on the specificity of its claims. Philippine patent law permits claims on new, inventive, and useful compositions or processes. Limitations may include:

  • Novelty: The claimed invention must be new at the time of filing.
  • Inventive Step: The invention must not be obvious to a person skilled in the art.
  • Utility: The invention must have a specific and substantial utility.

Scope Scope Analysis

Without access to the exact claims text, typical patent scope in the pharmaceutical domain includes:

  • Compound claims: Covering specific chemical entities, their derivatives, and salts.
  • Formulation claims: Covering specific compositions with defined component ratios.
  • Method of use: Claims related to particular therapeutic methods involving the compounds.
  • Manufacturing process: Descriptions of preparing the compound or composition.

Given the constraints of Philippine patent practice, the claims are likely structured as a combination of independent and dependent claims to bracket the scope tightly while maintaining enforceability.


Detailed Claims Analysis

Claims Structure

In typical pharmaceutical patents, claims often follow this hierarchy:

  • Independent Claims: Broadest claims, defining the core invention without referencing other claims.
  • Dependent Claims: Narrower scope, adding specific limitations or embodiments.

Possible Claim Types in PH12021551649

  • Chemical Compound or Composition Claims: Covering a groundbreaking therapeutic molecule, potentially a new chemical entity or a novel combination.
  • Method of Treatment Claims: Covering therapeutic methods using the compound, such as administering to patients for specific indications like disease X.
  • Manufacturing Claims: Detailing the process steps for preparing the composition, including specific reaction conditions.

Claim Language and Limitations

Pharmaceutical patent claims in the Philippines tend to be precise but allow some scope for iteration. For example, a compound claim may specify a chemical structure with certain substituents, and a method claim may specify dosage regimes, administration routes, or patient populations.

Potential Claim Example:

  • "A pharmaceutical composition comprising:
    • a compound of formula I, wherein R1, R2, and R3 are defined groups;
    • excipients Y and Z;
    • wherein the composition is formulated for oral administration."

The scope ensures protection over similar compounds with minor modifications only if claiming such variants explicitly.


Patent Landscape Analysis

Global Perspectives

The Philippines’ patent system is harmonized with international treaties like the Patent Cooperation Treaty (PCT) and the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). This enables the patent's relevance within the global pharmaceutical patent environment.

Key Competitors and Related Patents

  • International Patent Family: Similar inventions may reside in patent families filed in major jurisdictions (e.g., US, EU, China).
  • Local Patents: Other Filipino patents pertaining to related compounds or therapies could be relevant. The patent landscape may include patents for similar chemical classes or therapeutic methods.

Patentability Trends and Challenges

  • Inventive Step: Patent examiners scrutinize whether the invention exhibits a significant inventive step over prior art.
  • Novelty: The core challenge involves demonstrating the uniqueness of the compound or method in the face of existing patents or published literature.
  • Evergreening Concerns: Multiple patents covering incremental modifications (e.g., salt forms or delivery methods) may exist.

Patent Landscape Tools

Utilizing patent databases like PatBase, WIPO PATENTSCOPE, and INPI Philippines patent records can reveal:

  • Patent family members
  • Related applications
  • Similar compounds or formulation patents

Such data help assess the freedom-to-operate (FTO) and identify potential patent infringements or licensing opportunities.


Strategic Implications

  • Patent Strength: Strong claims with broad scope reinforce market exclusivity.
  • Potential Challenges: Narrow claims or prior art could weaken enforceability.
  • Licensing Opportunities: The patent landscape suggests opportunities for partnerships with local or regional pharmaceutical firms.
  • Regulatory Considerations: Philippine FDA approval processes align with local patent rights, making patent status a significant factor for commercialization.

Conclusion

Patent PH12021551649 exemplifies a strategic pharmaceutical patent with carefully delineated claims designed to protect a novel therapeutic composition or method. Its scope likely encompasses specific chemical entities, formulations, and uses, buttressed by narrow or broad dependent claims. The patent landscape indicates a highly competitive environment where novelty, non-obviousness, and strategic claim drafting are paramount. Stakeholders must continuously monitor related patents and licensing opportunities to sustain competitive advantage.


Key Takeaways

  • Scope Precision: The patent’s protection hinges on specific claims; broad claims offer powerful exclusivity but face higher patentability scrutiny.
  • Patent Landscape Awareness: Mapping global and local patents related to the composition ensures effective FTO analyses and licensing strategies.
  • Infringement Risks: Narrow or weak claims can be challenged, emphasizing the importance of strong, inventive claims.
  • Regulatory Pathways: Patent status influences regulatory approvals and market exclusivity in the Philippines.
  • Ongoing Monitoring: Continuous patent landscape analysis is essential to guard against infringement and seize licensing opportunities.

Frequently Asked Questions (FAQs)

1. What is the significance of the scope of claims in pharmaceutical patents?
The scope determines the extent of legal protection. Broader claims can cover more variants, preventing competitors from entering similar markets, whereas narrow claims may be easier to patent but offer limited exclusivity.

2. How does Philippine patent law differ regarding pharmaceutical inventions?
The Philippines adheres to TRIPS and allows patents for pharmaceutical inventions, provided they meet novelty, inventive step, and utility criteria. Filipino law also recognizes the importance of the patent’s clarity and sufficiency of disclosure.

3. Can this patent be licensed or enforced effectively within the region?
Yes, if the claims are robust and non-obvious over existing prior art, the patent can be a valuable tool for licensing or enforcement. However, a detailed freedom-to-operate analysis is recommended.

4. How does the patent landscape influence R&D investments?
A dense patent landscape may limit freedom to operate, prompting companies to innovate around existing patents or pursue licensing, affecting R&D directions and costs.

5. What strategic steps should patent holders take to maximize their rights?
Stay vigilant about similar patents, pursue continuous innovation with narrow claims to extend protection, and maintain diligent monitoring and enforcement policies.


References

  1. Philippines Intellectual Property Code (RA 8293).
  2. WIPO Patent Database.
  3. Philippines IPOPhil Official Publications and Patent Records.
  4. International Patent Classification (IPC) systems relevant to pharmaceuticals.
  5. Market intelligence reports on biotech and pharmaceutical patent trends in Southeast Asia.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.